The Mesothelioma Center News
New York’s MTA Ignored Asbestos Dangers for Years
- by Matt Mauney
- Asbestos Exposure & Bans
- Oct 8, 2019
Glaring safety issues involving asbestos exposure within the Metropolitan Transportation Authority extend further than the East New York bus depot in Brooklyn, a report from the agency’s inspector general…
Read More
Keytruda for Mesothelioma Flops in Phase III Clinical Trial
- by Matt Mauney
- Research & Clinical Trials
- Oct 7, 2019
Results from a phase III clinical trial comparing Keytruda (pembrolizumab) to standard chemotherapy shows the immunotherapy drug still has a long way to go as a viable treatment option for…
Read More
First Mesothelioma Patient Begins Newly Approved Treatment
- by Matt Mauney
- Treatment & Doctors
- Oct 1, 2019
A mesothelioma patient at West Cancer Center in Memphis, Tennessee, is the first in the country to use NovoTTF-100L, a noninvasive electric therapy treatment, since its approval by the U.S.
Read More
Inspector General Report: Asbestos Exposure a Concern on Army Posts
- by Matt Mauney
- Asbestos Exposure & Bans
- Sep 25, 2019
Residents in privatized housing on nearly 50 Army installations cited concerns with issues such as lead paint and asbestos, the toxic building material linked to mesothelioma cancer, according to…
Read More
Medicare Now Covers CAR T-Cell Therapy for Approved Cancers
- by Matt Mauney
- Treatment & Doctors
- Sep 19, 2019
A promising and expensive type of immunotherapy, called CAR T-cell therapy, is now covered by Medicare. This news may affect mesothelioma patients in the future. Chimeric antigen…
Read More
Mesothelioma Cells Slowed by Grape-Seed Extracts
- by Tim Povtak
- Research & Clinical Trials
- Sep 12, 2019
Extracts from two Italian grape varieties showed distinct anti-cancer activity in three different mesothelioma cell lines, according to a recent multicenter study in Naples, Italy. The in-vitro findings strongly suggest…
Read More
Asbestos in Makeup Leads to Recall of City Color Products
- by Matt Mauney
- Asbestos Exposure & Bans
- Sep 9, 2019
Beauty Plus Global Inc., the cosmetics and packaging manufacturer behind City Color and Max Mell, has issued a voluntary recall of four City Color makeup products that tested positive for…
Read More
Mesothelioma Clinical Trial Targets Latest Gene Therapy
- by Tim Povtak
- Research & Clinical Trials
- Sep 4, 2019
Pioneering pulmonologists Dr. Steven Albelda and Dr. Daniel Sterman have worked for more than 20 years on developing gene therapy to effectively combat pleural mesothelioma cancer. The payoff may…
Read More
MD Anderson Remains Top-Ranked Cancer Center
- by Tim Povtak
- Treatment & Doctors
- Aug 28, 2019
U.S. News & World Report named University of Texas MD Anderson Cancer Center in Houston as the No. 1 Adult Cancer Hospital in America for the fifth consecutive year.
Read More
Mesothelioma Study Explores New Treatment When Chemotherapy Fails
- by Tim Povtak
- Research & Clinical Trials
- Aug 26, 2019
A clinical trial is exploring whether a novel immunotherapy/antiangiogenic combination can serve as an effective second-line treatment for pleural mesothelioma. Early indications of the four-center, phase II clinical trial…
Read More
